Reversible Rituximab-Induced Bronchiectasis: A Pediatric Case Report and Literature Review
American Journal of Case Reports · 08.05.2026 · 27
DOI: 10.12659/ajcr.952043 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Case Reports, online erschienen am 08.05.2026. Verfasst von Nasser AlHarbi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonology Division, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Hauptthemen laut MEDLINE: Rituximab, Bronchiectasis, Immunologic Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pulmonology Division, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
- Department of Paediatric Pulmonology, King Khalid University Hospital, King Saud University Medical City, Riyadh, Saudi Arabia.
ORCID-Profile: Ahmed AlEidan
Zitieren
APA
AlHarbi, N., AlEidan, A., & AlZanbagi, M. A. (2026). Reversible Rituximab-Induced Bronchiectasis: A Pediatric Case Report and Literature Review. American Journal of Case Reports, 27. https://doi.org/10.12659/ajcr.952043
Vancouver
AlHarbi N, AlEidan A, AlZanbagi MA. Reversible Rituximab-Induced Bronchiectasis: A Pediatric Case Report and Literature Review. American Journal of Case Reports. 2026;27. doi:10.12659/ajcr.952043
BibTeX
@article{AlHarbi2026,
author = {AlHarbi, Nasser and AlEidan, Ahmed and AlZanbagi, Masheal A},
title = {Reversible Rituximab-Induced Bronchiectasis: A Pediatric Case Report and Literature Review},
journal = {American Journal of Case Reports},
year = {2026},
volume = {27},
doi = {10.12659/ajcr.952043}
}
EUVIMED